Document Detail


The timing of demise in fetuses with trisomy 21 and trisomy 18.
MedLine Citation:
PMID:  16032775     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Women with chromosomally abnormal fetuses often choose to continue their pregnancy. However, though they may search for specific details whether their fetus will survive, not much information is available. We sought to determine if there was a pattern for timing of demise and to determine if demise was more likely to occur before viability in fetuses with amniocentesis confirmed trisomy 18 or 21. METHODS: From the California Expanded AFP screening program, 1813 women were identified to have a fetus with trisomy 18 or 21. Of these, 392 women with trisomy 21 and 106 with trisomy 18 continued the pregnancy. Pregnancies ending in fetal demise were analyzed for gestational age at demise. RESULTS: Of the trisomy 21 fetuses, 40 (10.2%) demised and of the trisomy 18 fetuses, 34 (32.1%) demised. The mean gestational age at time of fetal demise was 28.9+/-1.3 weeks SE for trisomy 21 and 32.1+/-1.2 weeks SE for trisomy 18 (p=0.09). There was no clustering of losses as losses were uniformly distributed throughout gestation after 24 weeks. A slightly larger proportion of T-21 (37.1%) losses occurred before viability (24 weeks) compared to those with T-18 (14.8%) (p=0.05). CONCLUSION: It appears that after 24 weeks' gestation, there is no specific time for fetal demise in fetuses affected by trisomy 21 or 18. There may be an association between trisomy 21 and stillbirth prior to viability. This information may be helpful in counseling those patients found to have a chromosomally abnormal fetus who choose to continue their pregnancy.
Authors:
Rosa H Won; Robert J Currier; Fred Lorey; Dena R Towner
Related Documents :
10590425 - Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype.
10589055 - Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hcg ...
16570265 - Prenatal diagnosis of a nasal glioma in the mid trimester.
7977535 - Optimal nuchal skin-fold thresholds based on gestational age for prenatal detection of ...
2271195 - Ketamine induction and monoamine oxidase inhibitors.
15711675 - Outcome of pregnancies with preterm premature rupture of membranes.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  25     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-07-28     Completed Date:  2005-12-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  608-11     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2005 John Wiley & Sons, Ltd.
Affiliation:
Division of Maternal-Fetal Medicine, Department of OB/GYN, University of California, Davis, Sacramento, CA 95817, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amniocentesis / methods
Chromosomes, Human, Pair 18*
Down Syndrome
Female
Fetal Death
Genetic Counseling
Gestational Age
Humans
Pregnancy
Prenatal Diagnosis*
Trisomy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women.
Next Document:  Photochemistry of naphthalene diimides: EPR study of free radical formation via photoredox process.